BioDiscovery, Inc. Granted It’s Eighth Patent for Advanced Microarray Image Analysis

Share Article

BioDiscovery Inc., the leading developer of integrated software solutions for microarray research, was granted US patent number 7,099,502 for pioneering technology. The patent provides for automatically assessing the quality of data generated by microarrays, including spot and array level quality control measures. This patent is the company’s eighth in a series of patents covering fundamental aspects of image processing and data visualization methods used in microarray analysis.

BioDiscovery Inc., the leading developer of integrated software solutions for microarray research, was granted US patent number 7,099,502 for pioneering technology. The patent provides for automatically assessing the quality of data generated by microarrays, including spot and array level quality control measures. This patent is the company’s eighth in a series of patents covering fundamental aspects of image processing and data visualization methods used in microarray analysis.

Patent 7,099,502 demonstrates BioDiscovery’s dominance in core technologies for automatic processing of high density microarray images. In particular, this patent describes a method for accessing the digital image data, and determining a level of confidence in the signal characterizing output related to array image analysis. Some of the measures specified in the patent are the area of spots, area of a respective spot to an area of a respective signal, ellipticity of a respective signal, orientation of the ellipticity of a respective signal, degree of deviation of a respective signal from a circle, and many more quality measures.

“The importance of our intellectual property cannot be over-estimated to both our customers and to BioDiscovery” said Dr. Shams, BioDiscovery CEO. “To our customers, the growth of additional patents and related intellectual property demonstrates that the products they are using for their research is truly novel, using the most advanced technology. It further illustrates the key role that BioDiscovery has played in the growth and acceptance of array technology over the past decade, and its commitment to continuous cultivation of cutting edge science and analytics.”

BioDiscovery’s ImaGene 7.0 image processing software is the culmination of all the latest advancements in array image processing including advanced quality control, batch automation, and a new aCGH module. The optional batch automation has been strengthened with more accurate spot finding, and the ability to batch process aCGH arrays with no user intervention. These products continue to utilize our advanced and now patented methods for automatic quality control testing to minimize manual labor involved with visual inspection and improving down-stream analysis results.

About BioDiscovery

Founded in 1997 in Los Angeles, BioDiscovery is a leader in the development of microarray bioinformatics software and services. BioDiscovery develops and sells advanced software solutions and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology. BioDiscovery provides a full line of modular software packages spanning the entire microarray process, including enterprise data management, image processing, data mining, statistical analysis, and collaborative knowledge management. For more information about BioDiscovery, please visit the company’s website at http://www.biodiscovery.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Soheil Shams
Visit website